Brazil
https://mirsciencetx.com/
https://www.linkedin.com/company/mirscience-therapeutics/about/?viewAsMember=true
Mirscience Therapeutics
Health
Mirscience Therapeutics develops RNA-based oligonucleotides for age-related diseases. MT-29 targets key genes in sarcopenia via a proprietary platform combining RNA biology and machine learning to unlock non-coding RNA therapeutics
Wed
Thu
Fri
Sat
Healthcare & Wellness
Growth & Investment